Natera (NTRA) Enters Agreement with Bristol-Myers (BMY) for Signatera ctDNA Assay
Tweet Send to a Friend
Natera, Inc. (NASDAQ: NTRA) announced an agreement with Bristol-Myers Squibb (NYSE: BMY) to use Natera's Signatera™ custom circulating tumor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
